Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Vaccine to Prevent Adverse Vascular Events in Heart Failure
NCT02762851Phase 4Unknown
- Sponsor
- McMaster University
- Start
- Jun 2016
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 13
01
Overview
Phase 4, randomised trial in influenza comparing Influenza vaccine with Placebo vaccine (2 arms). Primary endpoint: Adverse cardiovascular event at 6 months. Status: unknown.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02762851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02762851.